Q2 2023 Maravai LifeSciences Holdings Inc Earnings Call Transcript
Thank you for standing by. I would like to welcome everyone to the Quarter 2 2023 Maravai LifeSciences' Earnings Conference Call. (Operator Instructions)
I will now turn the conference over to Debra Hart. Deb, please go ahead.
Good afternoon, everyone. Thanks for joining us on our second quarter 2023 earnings call. Our press release and the slides that accompany today's call are posted on our website and are available at investors.maravai.com.
As you can see on our agenda on Slide 2, joining me today are Trey Martin, our new CEO; Kevin Herde, Chief Financial Officer; and Carl Hull, Executive Chairman of the Board. Drew Burch, Executive Vice President and General Manager of our Nucleic Acid Products; and Becky Buzzeo, our Chief Commercial Officer, will join the call for the question-and-answer session following the prepared remarks.
We remind you, management will make forward-looking statements and refer to GAAP and non-GAAP financial measures during today's call
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |